Solidus Biosciences is Biotechnology in United States that focus on cell culture business. Founded in 2002. They cover business area such as developer, both compound, their metabolite, toxicity, decision-making, new product development, biotechnology, cosmetic, industry, researcher, new drug development, proprietary decision-enable technology, drug safety, efficiency, cost, productivity, investment, new drug research.
2002
( 22 years old in 2024 )
Cell Culture
-
409 Illinois Street
Suite 2073
San Francisco, CA 94158
United States
Private
developerboth compoundtheir metabolitetoxicitydecision-makingnew product developmentbiotechnologycosmeticindustryresearchernew drug developmentproprietary decision-enable technologydrug safetyefficiencycostproductivityinvestmentnew drug research
* We use standard office opening hours in near Solidus Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Solidus Biosciences is Biotechnology business from United States that founded in 2002 (22 years old in 2024), Solidus Biosciences business is focusing on Cell Culture.
Solidus Biosciences headquarter office and corporate office address is located in 409 Illinois Street Suite 2073 San Francisco, CA 94158 United States.
Solidus Biosciences was founded in United States.
In 2024, Solidus Biosciences is currently focus on cell culture sector.
Above is snippet of Google Trends for "cell culture" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Solidus Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
